While BRCA1/2 PVs have an extensive influence on tumourigenesis by affecting the tumour microenvironment, the differences in epigenetics of hereditary and sporadic breast cancers also predispose hereditary BRCA1 PV carriers and, to a lesser extent, BRCA2 ones, to the development of cancer. The gene discussed is BRCA2; the disease is breast carcinoma.